Rotech closes private offering of $290M in Senior Notes due 2018

NewsGuard 100/100 Score

Rotech Healthcare Inc. (OTCBB: ROHI) announced the closing of its previously announced offering of $290 million in aggregate principal amount of Senior Second Lien Notes due 2018.

Rotech expects to use the net proceeds received from the offering to repay all of its Senior Subordinated Notes due 2012, for payment of related fees and expenses and for general corporate purposes, as applicable, including funding the company's strategic priorities.

The notes were offered only to qualified institutional buyers in reliance on Rule 144A, to persons outside the United States under Regulation S, under the Securities Act, and to certain accredited investors as defined in Rule 501(a) under the Securities Act of 1933, as amended. The initial issuance of the notes was not registered under the Securities Act, and the notes may not be offered or sold without registration in the United States except pursuant to an exemption from the registration requirements of the Securities Act and applicable state securities laws.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Navigating the minefield of AI in healthcare: Balancing innovation with accuracy